📰 Medication Guide News

Page 44 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

AbbVie Provides Update Regarding SKYRIZI® (risankizumab-rzaa) for the Treatment of Moderate to Severe Crohn's Disease in the U.S.

February 28, 2022

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has extended its review period for SKYRIZI®...

Boehringer Ingelheim Drug Administration Exchange Commission Abbvie Inc Prescription Drug User Fee Act Important Safety

Source: prnewswire.com

KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma

February 25, 2022

25.02.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the ...

United States New Zealand Eisai Inc Eisai Europe Ltd Statement Of Merck Co Inc Exchange Commission

Source: wallstreet-online.de

Results of Novel Clinical Study Show Adults with Moderately to Severely Active Ulcerative Colitis Achieved Higher Rates of Clinical Response, Clinical Remission, and Endoscopic Improvement at 12 Weeks with Guselkumab and Golimumab Combination Therapy Versus Either Monotherapy Alone

February 19, 2022

SPRING HOUSE, Pa., Feb. 19, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson &amp; Johnson today announced data from a Phase 2a clinical trial that showed the combination of

United States Spring House British Columbia Brucee Sands Jan Wehkamp Bridget Kimmel

Source: wtva.com

XIAFLEX: A Nonsurgical Option for Peyronie's Disease (Sponsored)

February 18, 2022

XIAFLEX® is a nonsurgical treatment option for Peyronie’s disease, a condition that involves scar tissue along the penis and causes a curved erection. Learn more.

Medication Guide Mitigation Strategy

Source: everydayhealth.com

XIAFLEX (collaganese clostridium histolyticum) — A nonsurgical option (Ad)

February 18, 2022

XIAFLEX® is an FDA-approved nonsurgical treatment for Dupuytren’s contracture. Learn how this medication may help straighten the finger and improve range of motion.

Medication Guide Prescribing Information

Source: everydayhealth.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

The Majority of Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study Achieved Clinical Remission and Corticosteroid-Free Remission Through 48 Weeks with TREMFYA® (guselkumab)

February 18, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new results from the Phase 2 GALAXI 1 clinical trial showing the...

Spring House British Columbia United States Jan Wehkamp Bridget Kimmel None Of The Janssen Pharmaceutical Companies

Source: prnewswire.com

The Majority of Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study Achieved Clinical Remission and Corticosteroid-Free Remission Through 48 Weeks with TREMFYA® (guselkumab)

February 18, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new results from the Phase 2 GALAXI 1 clinical trial showing the...

Spring House British Columbia United States Jan Wehkamp Bridget Kimmel None Of The Janssen Pharmaceutical Companies

Source: prnewswire.com

Updates on OLUMIANT® (baricitinib) Phase 3 lupus program and FDA review for atopic dermatitis

January 28, 2022

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) today announced updates on the Phase 3 development program for OLUMIANT®...

United States Catalina Loveman Kevin Hern Christine Chiou Marlo Scott Eli Lilly

Source: prnewswire.com